Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Yufei Wang, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses challenges associated with implementing CAR T-cell approaches in solid tumors. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.